Ever Supreme signed MOU with more than 10 medical facilities, and to help extreme ill patients with better survival opportunities

Ever Supreme signed MOU with more than 10 medical facilities, and to help extreme ill patients with better survival opportunities

Taiwan FDA announced that the "RGSCTT " is officially launched. The new drug company of Taiwan-Ever Supreme Bio Technology has followed up and announced that it has completed signing a memorandum of understanding with more than 10 medical facilities such as China Medical University Hospital.   In the near future, diseases such as malignant tumors, stroke, acute myocardial infarction, and other acute and severe diseases could be treated under the applications of the cell therapy.  Once the FDA has approved, patients of such could be evaluated for appropriate cell therapy as treatment and to strive for better opportunities to survive. 

In addition, Ever Supreme is also committed to combining front-end R&D and back-end medical technology applications developed in the medical institutions, and is expected to create a globally competitive operational model.

Source: https://www.chinatimes.com/newspapers/20181108000474-260210